Isolated EVs from cHL cells degrade the artificial ADAM10-selective substrate PEPMCA001 and CD30, the latter resulting in a CD30 reduction to 71% of the inhibited control after 18 h of incubation. The gene discussed is ADAM10; the disease is classic Hodgkin lymphoma.